Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes

2017113 citationsJournal Article

Authors

Good health and well-being

Published in: European Urology

Volume 73, Issue 5, pp. 751-759

Field-Weighted Citation Impact: 13.81